Genetic testing issues examined at Trans-Tasman roundtable
31 July 2013
Genetic testing issues to be examined at Trans-Tasman roundtable
Ethical, legal and social aspects of the rapidly developing field of genetic testing will be the focus of discussion for top minds from both sides of the Tasman, gathering in Queenstown on Sunday (4 August) for the 4th Australia-New Zealand Roundtable on Genomics.
There will be two main sessions - one examining the issues surrounding prenatal testing for genetic disorders, while the other focusing on the managing of incidental findings and current issues in research involving Maori.
Both countries have produced significant research in the field, through the Australian Law Reform Commission (ALRC) reports on the protection of human genetic information and gene patents and the recent multi-year New Zealand Law Foundation-sponsored Human Genome Research Project (HGRP) which was led by the University of Otago’s Law Faculty.
This roundtable is jointly organised by the Centre for Society, Governance and Science (SoGoS), formed last year under the umbrella of the Otago Faculty of Law, and the Human Genetics Society of Australasia’s Ethics and Social Issues Committee (HGSA) with the support of NZ Genomics Ltd, Genetics Otago, Centre for Translational Cancer Research (University of Otago) and the New Zealand Law Foundation.
Earlier roundtables have examined a wide range of legal, ethical, cultural and policy issues generated by the rapid expansion of genetic knowledge and technology.
Otago Law Faculty Dean, Professor Mark Henaghan, says the roundtable meetings are incredibly valuable as a way of both sharing knowledge and bringing together a group of leading thinkers to work through the issues.
“We will be covering a variety of topics around which well-researched guidance and policy need to be discussed and developed so situations can be dealt with in a consistent manner as and when they arise.”
The first session will be chaired by Dr Jan Hodgson, Chair of the HGSA’s Ethics and Social Issues Committee.
“The first session will begin with comment from relevant experts on the scientific, practical, legal and ethical aspects of prenatal testing. Then a hypothetical clinical scenario will be introduced to generate discussion, touching on areas such as non-invasive prenatal screening (NIPS) to check if a foetus has any genetic abnormalities,” Dr Hodgson says.
The second session, chaired by Professor Ingrid Winship, the Australian partner who co-initiated the Roundtable, will look at current issues in research involving Maori and examine the whole area of incidental findings.
“The latter involves the question of how do we deal with unexpected findings from genetic testing that may be potentially more clinically important than the presenting disease itself?”
The roundtable discussion sessions will involve a number of distinguished academics and researchers including: Professor Winship, who is the Inaugural Chair of Adult Clinical Genetics at the University of Melbourne; Associate Professor Colin Gavaghan, Director of the New Zealand Law Foundation Centre for Law and Policy in Emerging Technologies at the University of Otago; Associate Professor Cris Print, joint Director of the New Zealand Bioinformatics Institute; and Associate Professor Clara Gaff, a certified genetic counsellor and a member of the HGSA Ethics and Social Issues Committee.
Roundtable attendees will also be addressed by Tony Lough, the CEO of NZ Genomics Ltd (NZGL), which is a collaboration involving the three universities - Otago, Massey and Auckland - with the Crown to deliver a genomics infrastructure to NZ researchers. NZGL is promoting the event to foster multi-disciplinary and public discussions about issues arising from health and medical uses of genomic technology.
More than 80 people are expected to attend the sessions. Organiser Richman Wee, from the Faculty of Law, says there is still space for late registrations.
The event is being held as part of the HGSA’s conference in Queenstown.
Key speakers - In order of participation during the Roundtable sessions:
1. Jan Hodgson, PhD
Jan Hodgson,
Chair of the Ethics and Social Issues Committee for HGSA
(ESIC), has worked in health care settings for many years as
a critical care nurse, counsellor and health educator. She
has a BSc (Hons) in Health Studies, a Graduate Diploma in
Genetic Counselling and a PhD. She is currently a Senior
Lecturer in the Department of Paediatrics at the University
of Melbourne and co-ordinates several components of the
Master of Genetic Counselling program including Reflective
Practice, Ethics, Health Communication and Healthcare
Research Methods. Jan’s PhD research, ‘Testing Times,
Challenging Choices’, explored women’s decision-making
about prenatal testing. Her current ARC-funded research is
‘A longitudinal study of women’s experiences following a
prenatal diagnosis of a fetal abnormality (The PeTALS
study)’. Jan is an experienced qualitative researcher and
is a Member Scholar of the International Institute of
Qualitative Methodology. Her other research interests
include medical and genetic communication, talking about
disability in prenatal settings, informed decision-making in
the context of non-directive genetic counselling, and
perinatal palliative care. Jan is a Board Member of the Down
Syndrome Association of Victoria.
2. Marleen Susman,
PhD
Marleen Susman completed her PhD in 2012,
supported by a Melbourne University Postgraduate
Scholarship. She originally completed a Bachelor of Science
in Genetics (and Biochemistry) at La Trobe University in
1975, before embarking on a career in clinical cytogenetics.
She has worked in many laboratories locally, as well as
overseas at the University of Newcastle, UK. Prior to
enrolling in her PhD, Marleen was the director of
Cytogenetic Services, a private cytogenetics laboratory in
Melbourne. During her career in cytogenetics, Marleen also
completed a Graduate Certificate in Scientific Writing, MSc
in History and Philosophy of Science (Science in Society),
Graduate Diploma in Genetic Counselling, and the FHGSA
(Cytogenetics). She is currently working as the Genetic
Support Coordinator at the Genetic Support Network of
Victoria, and as a Research Officer with Public Health
Genetics at the Murdoch Children’s Research Institute. In
addition to being a member of the HGSA ESIC Committee,
Marleen is a committee member of the Victorian branch of the
HGSA as well as the joint HGSA/RANZCOG Prenatal Diagnosis
and Screening Committee.
3. Ainsley Newson,
PhD
Ainsley Newson is Senior Lecturer in Bioethics at
the Centre for Values, Ethics and the Law in Medicine
(VELiM), University of Sydney, and is Coordinator of the
Sydney Bioethics Masters Program. Ainsley’s research
interests include ethical aspects of clinical and
reproductive decision-making in genetics - especially
prenatal diagnosis and family communication, genetics and
public health, mechanisms of clinical ethics support, and
ethical issues in emerging technologies such as synthetic
biology. Ainsley has Bachelor’s degrees in Science (human
genetics) and Law, and a PhD in Medical Ethics, all gained
from the University of Melbourne. She undertook postdoctoral
work in the Medical Ethics Unit at Imperial College London
and then worked for nearly seven years at the Centre for
Ethics in Medicine at the University of Bristol, being
promoted to Senior Lecturer in 2008. Ainsley has published
several papers dealing with the ethical aspects of
non-invasive prenatal testing (NIPT). She was a member of
the ethics work package of the SAFE Network (European
Commission, Framework 6) and, for three years, was a
co-investigator on the RAPID project (National Institute of
Health Research, UK). She has also spoken and written about
NIPT for the general public and media. Ainsley is a member
of ESIC and also a member of the Clinical Ethics Advisory
Panel for NSW Health.
4. Dr Sue White, MBBS,
FRACP
Sue White is a clinical geneticist at the
Victorian Clinical Genetics Services in Melbourne. She
studied medicine at Monash University, trained in
paediatrics in Melbourne and completed her genetics training
in Melbourne and Oxford. As a consultant geneticist she has
worked in Melbourne and at Great Ormond Street Hospital in
London. Her clinical work is primarily in dysmorphology and
prenatal diagnosis. In both areas, she has experienced the
challenges and opportunities that new technologies bring.
She is an honorary Senior Lecturer at University of
Melbourne and teaches medical students, paediatric doctors
and genetic counsellors. Her research is in dysmorphology in
the areas of gene discovery, phenotype delineation, the
impact of diagnoses on families, and communication between
doctors and families about dysmorphism. She has published
more than 35 peer-reviewed articles and two book chapters.
In her spare time, she raises two children, is completing a
Professional Writing and Editing degree at RMIT and writes
fiction for young adults.
5. Associate Professor Colin
Gavaghan
Colin Gavaghan is an Associate Professor in
the Faculty of Law at the University of Otago, where he is
also the first Director of the New Zealand Law Foundation
Centre for Law & Policy in Emerging Technologies. He has an
LLB (Hons) and a PhD from Glasgow University, where he
lectured prior to moving to Dunedin. He is the author of
‘Defending the Genetic Supermarket: the law and ethics of
selecting the next generation’ (Routledge-Cavendish,
2007), and has published on a wide range of issues
concerning the legal implications of genetics, neuroscience,
nanotechnology and medical practice.
6. Professor Mark
Henaghan
Mark specialises in family law and is a
Barrister and Solicitor of the High Court of New Zealand. He
is co-author of Family Law Policy in New Zealand (4th ed,
LexisNexis Butterworths, 2013) and joint author of Family
Law in New Zealand, (15th ed, LexisNexis Butterworths,
2012). Mark is the joint author of Relationship Property on
Death (Thomson Brookers, 2004) which won the 2005 J F
Northey prize for the best published law book in New
Zealand, Relationship Property Consolidated Legislation and
Analysis (Brookers Thomson Group, 2001) and sole author of
Care of Children (LexisNexis Butterworths, 2005). He is the
sole author of Health Professionals and Trust (Routledge,
2012). He is an author and member of the editorial board for
LexisNexis Family Law Service and the New Zealand Family Law
Journal and author of a number of articles on family law.
Mark is on the editorial boards of Child and Family Law
Quarterly (the leading UK journal on children’s issues),
The International Journal of Human Rights (the leading UK
journal on human rights) and Society, Governance and Science
(the new international and multidisciplinary electronic
journal). Mark was the principal investigator of the Human
Genome Research Project ‘Law, Ethics and Policy for the
Future: Te Kaupapa Rangahau Ira Tāngata’ that was funded
by the New Zealand Law Foundation.
7. Professor Ingrid
Winship
Professor Ingrid Winship was appointed as the
Inaugural Chair of Adult Clinical Genetics at the University
of Melbourne, and Executive Research Director for Melbourne
Health, in November 2006. Professor Winship has a wide range
of clinical and research interests in inherited disorders,
focusing on those with onset in adulthood, including
familial cancer, and where foreknowledge of genotype may
influence clinical or lifestyle measures to create positive
patient outcomes. She has experience in gene discovery and
in the translation of such discovery into clinical practice.
She has also highlighted societal implications of her
discipline with research into the ethical, legal, cultural
and psychosocial domains of genetic technology. She is a
member of the NHMRC Human Genetics Advisory Committee and
the Victorian Cancer Agency, a consultative council for
Victoria for cancer research. She is on the Board of the
Walter and Eliza Hall Institute, and on the Scientific
Advisory Council of the Bio21 Cluster, where she chairs the
Hospital Research Directors Forum.
8. Associate
Professor Cristin Print
Associate Professor Cristin
Print is a medically-qualified scientist (MBChB, PhD) who
works in the field of bioinformatics. He graduated from
Auckland Medical School in 1989, then worked as a house
surgeon and performed asthma research in Dunedin, before
completing a PhD at the University of Auckland. He worked
overseas for ten years investigating molecular changes in
disease, first at the Walter and Elisa Hall Institute in
Melbourne, Australia, then at Cambridge University, UK,
where he was a Fellow of St Edmund’s College. While
overseas he co-founded a Japanese biotechnology company in
the field of bioinformatics, and returned to the University
of Auckland where he works on clinical genomic research in
breast cancer, melanoma and colon cancer. Cris is currently
joint Director of the New Zealand Bioinformatics Institute
and Chair of the New Zealand Genomics Limited Project
Advisory Group.
9. Associate Professor Clara
Gaff
Clara Gaff is leading an initiative to introduce
genomics into health care in Melbourne. Clara completed a
PhD in molecular genetics before becoming a genetic
counsellor. She received the National Society of Genetic
Counselors’ inaugural International Award for her
achievements and leadership in genetic counselling
internationally. Clara is now manager of Genomic Medicine at
the Walter and Eliza Hall Institute and Principal Strategic
Development Officer at the Victorian Comprehensive Cancer
Centre. She is a member of ESIC and the NHMRC Human Genetic
Advisory Committee. Through honorary academic appointments
with The University of Melbourne and Murdoch Children’s
Research Institute, Clara continues to pursue her research
interests in the mainstreaming of genetics in clinical
practice, consent and genetic testing, and family
communication.
10. Phillip Wilcox, PhD
Phil
Wilcox is a molecular geneticist with experience in applied
genomics and statistical genetics. He is the current
convenor of MapNet, a NZ-wide collective of gene mapping
scientists (see https://mapnet.agresearch.co.nz/mediawiki/index.php/MapNet:About
) and the Project Leader of the Virtual Institute for
Statistical Genetics (www.visg.co.nz). He currently works
for Scion, a Crown Research Institute in Rotorua. Dr Wilcox
also established Te Aroturuki, a group of Maori scientists
and advisors who developed a process to assist Western
research scientists engage with Maori communities regarding
controversial technologies, and he has been working with
researchers at Universities of Otago and Waikato in
developing engagement processes with Maori communities in
relation to genomics and biobanking. Dr Wilcox is of Ngāti
Rakaipaaka, Rongomaiwahine, Ngāti Kahungunu ki te Wairoa
and Pākeha descent.
11. Jo Fitzpatrick
Jo
Fitzpatrick (tribal affiliation: Rongomaiwahine, Ngati
Kahungunu) has been active in the consumer health and
disability sector with a particular interest in informed
consent, especially in relation to rights in health and
disability services and health information. She was the
Director of Women’s Health Action Trust, an evidence-based
consumer advocacy organisation, for nine years. She has
represented consumers on National Screening Unit consumer
reference groups; HIV in Pregnancy and Breast Screening;
health information working groups; Standards NZ on health
information and fertility services; and the Trans-Tasman
Agency for Therapeutic Products Advertising Code
subcommittee. She has chaired the Health and Disability NGO
Working group, the NZ Consumer Collaboration, and the Health
Information Strategy Advisory Committee Consumer Forum. She
is a member of the National Health IT Board Consumer Forum,
an independent Board member of DiabetesNZ, a consumer
representative on Organ Donation NZ, a board member of the
Auckland Women’s Health Council, and a member of the
Institute of Directors. She has recently been appointed by
the Minister of Health to serve as a member of the Ethics
Committee on Assisted Reproductive Technology
(ECART).
Lead organiser for the 4th Australia-New Zealand Roundtable on Genomics:
Richman Wee,
LLM
Richman provides comments on the legal, ethical
and policy issues about the use of human tissue and personal
information for health research and biobanking, as well as
issues relating to clinical or research initiatives
involving genomic studies. He is involved with the Law
Foundation-sponsored Centre for Law and Policy in Emerging
Technologies, University of Otago. He initiated the proposal
for the international and multidisciplinary Centre for
Society, Governance and Science (SoGoS) that is led by the
Faculty of Law, University of Otago. He is an editorial
board member for the electronic-journal ‘Society,
Governance and Science’ and a member of ESIC. He was the
first policy advisor for the Health Research Council, and
the project manager and a researcher for the Law
Foundation-sponsored Human Genome Research Project ‘Law,
Ethics and Policy for the Future: Te Kaupapa Rangahau Ira
Tāngata’. He was appointed by the Health Ministers of
current and previous Governments to serve as the legal
member and chairperson for the Multi-Region Ethics
Committee.
About the organising bodies involved:
• Centre for Society, Governance and Science (led by the Faculty of Law, University of Otago; Co-Directors: Professor Mark Henaghan and Associate Professor Colin Gavaghan)
The Centre for Society, Governance & Science (SoGoS) promotes and undertakes research on the challenges of integrating medical and scientific advancements with society in the face of changing approaches being used to govern citizens and institutions, as well as their rights, relationships and responsibilities. SOGOS aims to be an internationally renowned multidisciplinary research centre or ‘think tank’ that undertakes research and policy development work for governments, professional bodies and NGOs for the public good. SoGoS was established in 2012 with objectives that include advancing ‘science in society’ initiatives and engaging with the public.
• Ethics and Social Issues Committee (ESIC) of the Human Genetics Society of Australasia (HGSA)
ESIC, a key committee of the HGSA, is responsible for offering expert opinion to Council and the Executive, and for developing and reviewing HGSA policy and position statements on a wide range of ethical issues.
ENDS